Pre-market Hot Trades in US Stocks
C3is is down 19.13% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 18, C3is announced its first-quarter financial report, with adjusted net income increasing by 358% year-on-year, adjusted EBITDA growing by 130%, and cash balance rising by 82%. However, the market reacted negatively, causing the stock price to drop 19.13% in pre-market trading. Source: Reuters
</li>
<li>
On May 18, C3is announced a fleet expansion plan, adding two product tankers. Although the expansion plan shows potential for future growth, the market expressed concerns about short-term financial pressure, leading to a decline in stock price. Source: Reuters
</li>
<li>
On May 18, C3is mentioned the impact of geopolitical tensions on market conditions during a conference call. Despite the company's strong financial position, investors expressed concerns about future uncertainties, putting pressure on the stock price. Source: Reuters Geopolitical tensions affect market conditions.
</li>
</ol>
Jianzhi Edu Tech is down 13.67% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Top Gainers in Pre-market US Stocks
Amesite is up 261.20% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 18, Amesite CEO Ann Marie Sastry purchased 174,216 shares of common stock at a price of $1.44 per share. This move increased her direct holdings and included the purchase of corresponding warrants, demonstrating confidence in the company's future and driving the stock price up.
</li>
<li>
On May 18, director George Parmer purchased 243,902 shares of Amesite common stock, also at a price of $1.44 per share. This move increased his holdings and included the purchase of corresponding warrants, further enhancing market trust in the company's management and promoting the stock price rise.
</li>
<li>
On May 18, Amesite announced its quarterly financial report. Although the net loss narrowed to $2.05 million, there are still significant doubts about its ability to continue operations. The company is shifting its strategy towards medical AI solutions and successfully raised $2.6 million, showing signs of financial improvement. The industry transformation and AI solutions are gaining attention.
</li>
</ol>
MetaVia is up 80.18% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 18, MetaVia released a major product update, and the market reacted positively. The company announced a new technological breakthrough expected to significantly enhance its product performance and market competitiveness, leading to a substantial increase in stock price.
</li>
<li>
On May 18, MetaVia received important industry certification, boosting market confidence. This certification further validates the company's technological leadership, attracting significant investor interest and driving the stock price up
On May 18th, MetaVia reached a strategic cooperation agreement with a large enterprise, which is expected to bring significant revenue growth. The signing of the cooperation agreement indicates a broad future development prospect for the company, leading investors to buy stocks, resulting in a surge in stock prices. The technology sector has performed strongly recently, boosting investor confidence.
</li>
</ol>
Haoxi Health Tech rose 79.21% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation

CISS

C3is pre-market down 19.13%; Jianzhi Edu Tech pre-market down 13.67%; Amesite pre-market up 261.20%; MetaVia pre-market up 80.18%; Haoxi Health Tech pre-market up 79.21%

Price Alert

C3is

Pre-market hot trades in US stocks: C3is pre-market down 19.13%; Jianzhi Edu Tech pre-market down 13.67%